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ORIGINAL ARTICLE
The accurate characterization and preoperative
staging of gastric tumors are important for plan-
ning the most appropriate therapy and for pre-
dicting prognosis. Traditionally, double-contrast
barium meal (DCBM) or optical endoscopic
studies have been used as the primary tool 
for preoperative diagnosis.1 However, these two
methods are considered as stressful and uncom-
fortable to patients. Recent advances in com-
puted tomography technology, including the
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Background/Purpose: Recent three-dimensional multidetector row computed tomography (3D MDCT)
can provide detailed images of a gastric tumor, including its general contour, location and depth. We
therefore evaluated the efficacy of MDCT in the differential diagnosis and staging of gastric tumors in pa-
tients prepared for surgery.
Methods: Seventy-nine patients with gastric tumors identified by gastric optical endoscopy were admitted
for preoperative evaluation. All patients received double-contrast barium meal (DCBM) study and ab-
dominal MDCT with 3D reconstruction before surgery. We compared the accuracy of MDCT with DCBM
study in detecting and differentiating gastric tumors. In addition, the MDCT findings were correlated with
surgical and pathologic results in gastric cancers for Borrmann type, T and N stages.
Results: Among the 79 patients with gastric tumors, there were 24 cases of early gastric cancer, 40 cases of
advanced gastric cancer, 12 cases of gastrointestinal stromal tumor, and three cases of gastric lymphoma.
Both MDCT and DCBM were very accurate in picking up the lesions (100%). The diagnostic accuracies of
MDCT and DCBM were similar (94% vs. 96%) in differentiating mucosal and submucosal lesions as well as
classification of Borrmann type in advanced gastric cancer (70% vs. 63%). In 64 patients with gastric cancers,
there was good correlation between MDCT images and pathology in 73% of T staging and 69% of N staging.
Conclusion: MDCT has a similar high accuracy in the preoperative diagnosis of different gastric tumors
compared with DCBM and provides additional information including tumor depth, lymph node and he-
patic metastasis. Therefore, MDCT may be used as a primary tool for preoperative tumor diagnosis and
staging. [J Formos Med Assoc 2007;106(11):943–952]
Key Words: barium sulfate, computed tomography, diagnostic use, neoplasms, stomach
©2007 Elsevier & Formosan Medical Association
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Departments of 1Medical Imaging, 2Internal Medicine, 3Surgery, and 4Pathology, National Taiwan University Hospital, Taipei, Taiwan.
Received: January 22, 2007
Revised: March 27, 2007
Accepted: August 7, 2007
*Correspondence to: Dr Yuk Ming-Tsang, Department of Medical Imaging, National Taiwan University
Hospital, 7 Chung-Shan South Road, Taipei 100, Taiwan.
E mail: mintsang@gmail.com
B.B. Chen, et al
944 J Formos Med Assoc | 2007 • Vol 106 • No 11
introduction of multidetector row computed to-
mography (MDCT) and the development of real-
time three-dimensional imaging systems, offer
great potential for the clinical evaluation of gastric
lesions.2–4 Some authors claim that 3D MDCT can
provide transient transparent projection (TTP)
images to replace DCBM and virtual gastroscopy
(VG) images to replace optical endoscopy,3 and we
believe that at least it would provide a topographic
view of a lesion that would be complementary to
the diagnosis. In addition, in patients with sus-
pected gastric cancer, MDCT can provide major in-
formation that influence the prognosis, including
the depth of wall invasion, the presence or absence
of lymph node and/or distant metastasis.5,6
Most previous studies of MDCT have focused
on its performance in detecting gastric cancers,
but other gastric tumors (such as gastrointestinal
stromal tumor [GIST] and gastric lymphoma) that
also require preoperative staging were not evalu-
ated.4–12 In this study, MDCT findings of gastric
lesions using 3D reconstruction were correlated
with surgical and pathologic results to assess its
utility and limitation in preoperative diagnosis and
staging. We assessed if MDCT could be used as a
primary tool, replacing the role of DCBM, to
evaluate gastric lesions in patients with suspicious
gastric tumors.
Material and Methods
Patients
Between February 2004 and January 2007, 79 pa-
tients (46 men, 33 women; mean age, 63 years;
age range, 32–87 years) with recent (within 1
week before admission) optical endoscopic find-
ings suggestive of a gastric tumor were admitted
for further evaluation. All received DCBM and
abdominal MDCT examination for preoperative
tumor localization and diagnosis. Postoperative
specimens were available in the patients, and
MDCT as well as DCBM findings were correlated
with the surgical and histopathologic results. All
patients gave their written informed consent be-
fore the examinations.
CT examination
CT examinations were performed using a 
commercially available multidetector row CT
scanner (LightSpeed QXi; GE Medical Systems,
Milwaukee, WI, USA) which possessed 16 rows
of detector arrays. Before CT examination, each
patient was prepared by overnight fasting to empty
the stomach. Butyl scopolamine (10 mg) was ad-
ministered intravenously in all cases to reduce
bowel peristalsis. Patients were advised to ingest
two packs of effervescent granules with minimal
water to obtain gastric distension. After a scout
projection confirmed optimal air distension of the
stomach, CT scanning was performed from the
diaphragmatic dome to the lower edge of the stom-
ach during a single breath-hold of 7–10 seconds.
Unenhanced CT scanning was done in supine
and prone positions. Scanning CT parameters in-
cluded 16 × 1.25-mm beam collimation, 1.2 mm
slice thickness, 2.5 mm reconstruction interval, 
a pitch of 6, 0.8 seconds gantry rotation time,
table feed of 7.5 mm/rotation, field of view to 
fit the size of the individual patient (usually
around 30–35 cm), 120 kVp and 80 mA. We re-
duced the tube current to decrease the radiation
dose. Scanning in the supine and prone posi-
tions helped to shift fluid (gastric secretion) that
might obscure underlying lesions and to distend
the collapsed segments that were dependent on the
opposite position. Preliminary evaluation of the
air-distended stomach would serve to localize a
potential lesion and to determine the body posi-
tion for the post-contrast scan so that a potential
lesion would be in the dependent portion of the
stomach and covered by water. For post-contrast
CT, all patients ingested 300–600 mL of tap
water to distend the stomach. This allows good
visualization of the enhancing gastric wall and
avoids overshooting artifacts due to intraluminal
air obscuring the normal gastric wall pattern.4,13
Thus, patients were scanned in the supine posi-
tion when lesions were in the high gastric body to
cardia; otherwise, they were scanned in the prone
position. Each patient received an intravenous dose
of 100 mL of contrast material at a rate of 3 mL/s.
In our experience, it was adequate that the scan
was initiated 50 seconds after the start of injec-
tion of contrast material for evaluation of tumor
depth, extragastric invasion and hepatic metas-
tasis. For post-contrast CT, the tube current was
increased to 210 mA to improve the spatial reso-
lution, and covered the diaphragm, liver and the
entire stomach.
DCBM study
The DCBM study was usually performed on the
day after CT examination. All studies were per-
formed after oral administration of 200–250 mL
of 220% wt/vol EZ-HD barium sulfate suspension
(EZ-EM, USA). Oral administration of an efferves-
cent powder and an intramuscular injection of
butyl scopolamine (10 mg) were used to establish
adequate gastric distension and to minimize peri-
staltic activity. Multiple spot radiographs were
obtained in various body positions under fluoro-
scopic control after adequate mucosal coating.
Image analysis
All preoperative images from DCBM and MDCT
studies were reviewed by two radiologists in con-
sensus without knowledge of the optical endo-
scopic findings and tumor location. If advanced
gastric cancer was suspected, the tumors were
classified according to the Borrmann system. If
the mucosal layer was intact over a mass, a sub-
mucosal tumor would be considered. If the mu-
cosal layer was unevenly thickened and showed
abnormal enhancement on MDCT, a mucosal le-
sion or gastric cancer would be diagnosed. Early
gastric cancer with ulceration would be considered
when focal interruption of mucosa with adjacent
nodularity or thickening was found. If only focal
interruption of the mucosal layer was found, a
benign gastric ulcer would be considered.
The CT dataset of each patient was transferred
to an image processing workstation equipped with
ADW 4.1 software (GE Medical Systems) for 3D
reconstruction. Orthogonal sectional images of
0.6 mm thickness would be routinely obtained.
Normally, one set of data would consist of three
subsets of roughly 200 slices. The total evalua-
tion time was about 15–20 minutes.
The precontrast images (where the stomach
had been distended by effervescent powder) would
undergo volume rendering to produce images: (1)
profile of the entire air-distended stomach (TTP);
(2) luminal surface view of the stomach mimick-
ing optical endoscopy (hence VG). The gross ap-
pearance of a lesion under VG views provided a
virtual gross view of the lesion with regard to its
nature, e.g. margin of the lesion, smoothness of
the tumor surface, presence of ulceration, nature
of the adjacent mucosal folds.
The postcontrast images would be evaluated
to identify focal wall thickening. The mucosal
(inner) layer which is usually well enhanced
would have higher attenuation than the less 
enhanced submucosal (middle) and muscular-
serosal (outer) layers. Staging of T stage on
MDCT was done according to the following:14 T1
(invasion to the mucosa or the submucosa, early
gastric cancer), when the tumor was confined to
the inner or middle layer of the gastric wall, with
thickening of the mucosal layer but no obvious
submucosal enhancement; T2 (invasion to the
proper muscle), when the tumor invasion ex-
tended to the outer layer of the gastric wall but
the outer surface of the gastric wall is smooth,
with thickening of the inner layer and marked
submucosal enhancement, or short stranding on
the serosal surface less than 5 mm in length; T3
(invasion to the serosa), when a nodular or irreg-
ular surface of the gastric wall or perigastric infil-
tration was evident, with long stranding or a
bumpy nodular appearance on the serosal sur-
face greater than 5 mm; and T4 (invasion to adja-
cent organs or structures), when direct invasion
or invasion of the tumor into a contiguous organ
or structures was evident. A lymph node with 
no fat content and size (short-axis) larger than
1 cm, or a cluster of three or more nodes would
be considered positive for metastasis. Imaging–
pathologic correlations of lymph nodes were
performed using group-by-group analysis. Our CT
staging method for nodal metastasis was based on
the nomenclature of the American Joint Commit-
tee on Cancer and the International Union Against
Cancer.15
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The pathologic reports of surgery specimens
were reviewed. Histologic T staging was based on
the international TNM classification. A stage of
pT1 indicated tumor invasion into the lamina
propria or submucosal layer; a stage of pT2,
tumor invasion into the muscularis propria or
subserosa; a stage of pT3, tumor penetration into
the serosa without invasion of adjacent structures;
and a stage of pT4, tumor invasion into adjacent
structures.16 The location and morphology of the
tumor, as described in the pathologic report, were
used as a gold standard to calculate the preoper-
ative diagnostic accuracies of DCBM and MDCT
examinations. The accuracy of MDCT examination
in the assessment of gastric cancer was also calcu-
lated, including Borrmann type, T staging and N
staging. We used McNemar’s test to compare the
diagnostic performance of DCBM and MDCT.
Results
In the 79 patients, the final pathologic diagnoses
were: 24 cases of early gastric cancer (EGC), 40
cases of advanced gastric cancer (AGC), 12 cases of
GIST, and three cases of gastric lymphoma. All
patients underwent operation for tumor excision
except two cases of gastric lymphoma (totalgastrec-
tomy in 12, subtotal gastrectomy in 54, wedge re-
section in 11 and biopsy in 2). The tumors were
located in the antrum (n = 34), the body (n = 24),
the cardia (n = 9), the fundus (n = 6), or both body
and antrum (n = 6) of the stomach. Hepatic
metastasis was noted in six patients, all of whom
had AGC.
All 12 patients with GIST presented with sub-
mucosal tumors on pathology, and did not have 
extraserosal invasion, lymph node or distant
metastasis. One of the three patients with gastric
lymphoma received total gastrectomy, and
pathology showed extraserosal invasion without
lymph node or distant metastasis. The other two
cases received only biopsy without surgery.
Diagnostic accuracy of MDCT and 
DCBM for gastric tumors
The preoperative localization of gastric tumors was
correctly assigned in all cases with both MDCT
and DCBM. The accuracy for differentiating 
mucosal and submucosal tumors was high in
both MDCT (94%) and DCBM (96%) (p = 0.62)
(Table 1). The overall accuracies of MDCT and
DCBM in the morphologic classification of AGC
were 70% and 63%, respectively (p = 0.45) (Table
2). The performance of MDCT was similar to
that of DCBM.
T and N staging of gastric cancer 
with MDCT
The appearance of EGC included thickened layer of
mucosa (Figures 1 and 2), while the appearance of
AGC included abnormal enhancement extending
Table 1. Diagnostic accuracy of multidetector row computed tomography (MDCT) and double-contrast
barium meal (DCBM) study for differentiating mucosal and submucosal tumors (n = 79)
Tumor type n MDCT DCBM p
Mucosal tumors (EGC, AGC) 64 61 (3 submucosal) 62 (2 submucosal)
Submucosal tumors (GIST, lymphoma) 15 13 (2 mucosal) 14 (1 mucosal)
Total 79 74 (94%) 76 (96%) 0.62
EGC = early gastric cancer; AGC = advanced gastric cancer; GIST = gastrointestinal stromal tumor.
Table 2. Diagnostic accuracy of multidetector row
computed tomography (MDCT) and
double-contrast barium meal (DCBM) 
for Borrmann classification of advanced
gastric cancer (n = 40)
Borrmann type n MDCT DCBM p
1 3 2 2
2 9 6 5
3 21 15 15
4 7 5 3
Total 40 28 (70%) 25 (63%) 0.45
MDCT vs. barium meal in preoperative gastric tumor detection
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deep into thickened submucosa, bumpiness and
long stranding appearance on serosal surface
that was more than 5 mm in height (Figures 3
and 4). A central depression in a tumor by VG was
considered to be an ulcer. When the well-enhanced
thin mucosal layer was smooth and only the less
enhanced submucosal layer was thickened, a sub-
mucosal lesion was considered, e.g. lymphoma
or GIST. Lymphoma presented with infiltrative 
submucosal mass whose extent was ill-defined
whereas GIST was a well-demarcated lesion
(Figure 5). An umbilication might be present on
the surface of the lesion indicating ulceration.
The accuracy of CT in the preoperative determi-
nation of T stages was 73% (Table 3). Over-staging
was more common in patients with T1-stage 
lesions and under-staging was more common 
in patients with T3-stage lesions using MDCT.
A B
C
Figure 1. Early gastric cancer type IIc in a 64-year-old
woman. (A) Axial contrast-enhanced computed tomography
shows mild thickening (arrows) at the posterior wall of the
stomach. The distinction between the well-enhanced mu-
cosal and less enhanced submucosal layers is clear. (B) The
lesion (arrows) is also demonstrated on the transient trans-
parent projection image, which resembles the images from
double-contrast barium meal study. (C) Virtual gastroscopy
image shows a superficial protruding lesion (arrows) at the
gastric angle.
A B
Figure 2. Early gastric cancer type IIb in a 71-year-old woman. (A) Double-contrast barium meal study shows a small
ulcer with retraction of the greater curvature side towards a tiny ulcer (arrow) at the antrum of the stomach. (B) Coronal
reconstructed image displays mucosal thickening spotted with tiny interruption at the center due to ulceration in the
antrum of the stomach (arrows).
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948 J Formos Med Assoc | 2007 • Vol 106 • No 11
For preoperative determination of nodal stage
(Table 4), MDCT had 69% (44/64) accuracy. For
lymph node involvement, MDCT showed 88%
sensitivity and 80% specificity.
Discussion
Traditionally, DCBM has been employed to 
detect or display the gross appearance of one 
gastric lesion that has been picked up by an 
endoscopist. Until recently, CT would be pre-
scribed to obtain further information on the 
extent of the lesion, nodal involvement, or pres-
ence of hepatic metastasis. Recent 3D MDCT can
provide TTP images similar to DCBM study, in-
cluding general contour of the stomach, gross
appearance and location of the gastric lesion.
Therefore, we believe that the use of 3D MDCT
may replace the role of DCBM in preoperative
A B
Figure 3. Advanced T3 gastric cancer (Borrmann type 2) in a 47-year-old woman. (A) Coronal reconstructed image
shows a protruding mass (arrows) with obvious submucosal enhancement in the antrum of the stomach with extragas-
tric soft tissue invasion (arrowhead). Surgically, it proved to be pathologic stage T3. There is a cluster of small nodes
(curved arrow) around the perigastric region, suggesting metastatic lymph nodes. Pathologic findings confirmed
metastatic nodes. (B) Virtual gastroscopy image depicts a polypoid tumor with a smooth border (arrows). Borrmann type
2 gastric cancer was reported by optical endoscopy and confirmed by pathology.
A B
Figure 4. Advanced T4 gastric cancer (Borrmann type 4) in a 70-year-old man. (A) Double-contrast barium meal study
shows an irregular mass (arrows) at the body of the stomach. (B) Postcontrast axial reconstructed image shows a focal
transmural hyperintense tumor (arrows) with an irregular outer border of the stomach and reticular strands in the greater
omentum contiguous to the outer border of the tumor (arrowheads) in the inferior wall of the gastric antrum, suggesting
omental invasion. Surgically, it proved to be pathologic stage T4 with omental involvement. The thickened mucosal layer
with intense transmural enhancement, which is more clearly demonstrated in the multiplanar reconstructed image, is
helpful to distinguish from submucosal tumor such as lymphoma.
MDCT vs. barium meal in preoperative gastric tumor detection
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tumor evaluation, and our results support that
belief.
Our study showed that MDCT and DCBM had
similar diagnostic accuracies in differentiating
mucosal and submucosal tumors as well as clas-
sification of Borrmann type in AGC. It is notewor-
thy that appropriate gastric distension and mucosal
enhancement were crucial in MDCT performance.
When the gastric mucosa was not well distended
or enhanced, it was difficult to differentiate 
mucosal from submucosal tumors as well as EGC
from AGC because the folds were clumped to-
gether, giving a feeling of abnormal enhancement
of the submucosal or muscular–serosal layer.
MDCT has several advantages over DCBM
study. First, combining reconstructed MPR images
and VG images provide information regarding the
gross behavior of the lesion (i.e. Borrmann’s clas-
sification). Second, MDCT provides information
concerning the depth of invasion by the tumor,
A B
C D
Figure 5. Gastrointestinal stromal tumor (GIST) in a 59-year-old woman. (A) Double-contrast barium meal study shows
a submucosal tumor (arrows) with intact smooth mucosa coating in the high body of the stomach. (B) Sagittal recon-
structed image displays a submucosal protruding mass of gastric body (arrows) with ulceration (asterisk). The overlying
mucosa appears as a smooth thin white line with interruption at the ulcer and the submucosal portion is moderately en-
hanced. The demarcation of well-enhanced mucosal layer and less-enhanced submucosal layer is still preserved, which
helps to differentiate from mucosal tumors such as advanced gastric cancer Borrmann type I. (C) Virtual gastroscopy
image shows a protruding mass with a smooth border and central ulceration (asterisk). (D) Endoscopy displays the same
findings as virtual gastroscopy of a protruding mass with central ulceration (asterisk). The patient received laparoscopic
assisted wide excision of the tumor and pathology revealed GIST.
the presence of extragastric invasion, lym-
phadenopathy and distant metastasis, which can-
not be seen in DCBM study. Third, MDCT is less
skill-dependent, with less discomfort to the patient
and thus more tolerable than DCBM study, espe-
cially in patients who are unable to cooperate
with the examiner.
On unenhanced CT scan used for reconstruc-
tion of VG, the tube current is lowered to 80 mA
and the patient scanned in the supine and prone
positions because the presence of air–fluid level
may immerge the underlying mucosa.12 Higher
mA (210 mA) on contrast-enhanced CT could
provide better spatial and contrast resolution in
the evaluation of tumor depth, extragastric inva-
sion and hepatic metastasis.
The advantages of VG include a wider field of
view than optical endoscopy and the ability to
freely adjust or navigate the viewing direction, so
that tiny lesions are not obscured by very sharp
turns.12,17,18 VG may provide alternative imaging
for a patient in whom optical endoscopy or DCBM
are not suitable (e.g. presence of severe obstruc-
tion). Elevated lesions are better depicted than
non-elevated lesions such as ECG 2b and 2c.
Malignant converging folds with clubbing or fu-
sion, which are not depicted on MPR images
alone, may be well-demonstrated by VG.19 In ad-
dition, fine mucosal details, color changes, texture,
and hyperemia are native to optical endoscopy.
New techniques such as color coding in propor-
tion to the gastric wall thickness or texture mapping
are works in progress that will hopefully overcome
these problems.17 In short, MDCT may provide
information that is comparable to that obtained
by both optical endoscopy and DCBM with the
addition of very important information such as
extragastric invasion, nodal involvement, and
hepatic metastasis for preoperative planning.17,20
Accurate evaluation of the local extent of gas-
tric cancer (the so-called T stage) is of pivotal 
importance in the choice of optimal therapeutic
strategy. Small T1 cancers have been shown to
have a very low rate of nodal involvement; there-
fore, such patients would be good candidates for
minimally invasive surgery such as endoscopic
mucosal resection or laparoscopic surgical resec-
tion.21 In particular, depiction of serosal invasion
is important because serosal involvement has
been demonstrated to be a poor prognostic fac-
tor.22,23 When locally advanced gastric cancer with
serosal invasion is present, a trial treatment with
preoperative neoadjuvant chemotherapy is un-
dertaken for down-staging to increase the chance
for curative resection.24,25 Our results suggest that
depth prediction solely by the enhancement of
the submucosal layer may be inadequate. It has
also been shown that the T staging of MDCT was
limited in some cases such as T1 cancer with mas-
sive submucosal invasion of the cancer cells, T2
B.B. Chen, et al
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Table 3. Diagnostic accuracy of multidetector row
computed tomography for each T stage 
in gastric cancer with pathologic results
as the reference standard (n = 64)*
Pathologic staging
CT staging
cT1 cT2 cT3 cT4 Total
pT1 18 5 1 24
pT2 1 10 1 12
pT3 1 7 15 23
pT4 1 4 5
Total 20 22 18 4 64
*Overall accuracy of T staging is 73%. cT = T staging by multide-
tector row computed tomography; pT = T staging by pathology.
Table 4. Diagnostic accuracy of multidetector row
computed tomography for each N stage
in gastric cancer with pathologic results
as the reference standard (n = 64)*
Pathologic staging
CT staging
cN0 cN1 cN2 cN3 Total
pN0 24 3 3 30
pN1 4 11 2 17
pN2 4 5 2 11
pN3 2 4 6
Total 28 20 10 6 64
*Overall accuracy of N staging was 69%, overall sensitivity was
88% and overall specificity was 80%. cN = N staging by multide-
tector row computed tomography; pN = N staging by pathology;
N0 = no regional lymph node metastasis; N1 = 1–6 regional
lymph node metastases; N2 = 7–15 regional lymph node metas-
tases; N3 = more than 15 regional lymph node metastases.
cancers with perigastric inflammation or vascular
or lymphatic engorgement, and T3 cancers with
minimal infiltration of cancer cells into the peri-
gastric adipose tissue.12 In a previous study, mul-
tidetector row CT scanning of patients with gastric
cancer gave 93% accuracy in the assessment of
serosal invasion in patients with gastric cancer.10
Our results showed only 65% (15/23) sensitivity
for serosal invasion, which might be due to a
stricter criterion in our study. Only those with
bumpy projection more than 5 mm in height
would be considered positive, otherwise inflam-
mation would be considered.
In previous reports, regional lymph nodes are
considered to be involved when the short axis di-
ameter is greater than 6 mm for perigastric lymph
nodes and greater than 8 mm for extraperigastric
lymph nodes.26 When lymph nodes are larger
than 10 mm in diameter, they are considered
positive if CT attenuation values are greater than
100 HU.27 In our study, we considered a lymph
node with no fat content and size larger than
1 cm, or a cluster of three or more nodes indicat-
ing positivity for invasion. But this criterion only
showed 88% sensitivity and 80% specificity.
Although there is a clear correlation between
lymph node size and cancer involvement, CT has
significant inherent limitations in the nodal stag-
ing of gastric cancer because of the high frequency
of microscopic nodal invasion (involvement of
normal-size nodes) and the poor differentiation
between reactive or inflammatory or metastatic
nodal enlargement.
The limitation of our study is that it was ret-
rospective and included only patients referred to
our hospital for further assessment and surgery.
Although blinded to the endoscopic, surgical and
histopathologic results, the observers were aware
of the presence of a tumor. The study may there-
fore be biased toward patients with more advanced
disease and result in a higher diagnostic rate of gas-
tric cancers. In addition, we only performed single
phase (50 s) in contrast-enhanced images, which
might decrease the accuracy for T staging.19
However, dynamic technique would increase the
radiation dose and we suggested that combination
of the VG and MPR might still provide similar di-
agnostic information for TNM staging of gastric
tumors.
In conclusion, MDCT has high accuracy in the
preoperative diagnosis of different gastric lesions
and provides valuable information including
tumor depth, morphology, lymph node and 
hepatic metastasis in only one examination. It is
unlikely for MDCT to replace the role of optic
endoscopy because MDCT cannot take biopsy of
the suspected gastric lesion. However, with its
improved performance and 3D reconstruction,
MDCT may be used as the primary tool and 
replace DCBM study in the preoperative diagnosis
of patients with gastric tumors.
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